• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Public Health Pract (Oxf) . SARS-CoV-2 seroprevalence among cancer patients and household caregivers in a cancer hospital: Cross-sectional survey af

tetano

Editor, Senior Moderator
Public Health Pract (Oxf)


. 2022 Dec;4:100341.
doi: 10.1016/j.puhip.2022.100341. Epub 2022 Nov 6.
SARS-CoV-2 seroprevalence among cancer patients and household caregivers in a cancer hospital: Cross-sectional survey after the second COVID-19 wave in Thailand


Teerapat Ungtrakul[SUP] 1 [/SUP], Gaidganok Sornsamdang[SUP] 2 [/SUP], Kamonwan Soonklang[SUP] 3 [/SUP], Siriporn Saeloo[SUP] 3 [/SUP], Kasiruck Wittayasak[SUP] 3 [/SUP], Ornpreya Suptawiwat[SUP] 1 [/SUP], Rojjanaporn Pulmanausahakul[SUP] 1 [/SUP], Nanthida Phattraprayoon[SUP] 1 [/SUP], Chirayu Auewarakul[SUP] 1 [/SUP], Nithi Mahanonda[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: Patients with cancer may be at an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and experience more severe outcomes. Low vaccine coverage in the early phase of the coronavirus disease 2019 (COVID-19) pandemic meant that personal and social measures to reduce viral spread were the only methods of lowering the risk of infection among cancer patients. This study explored the prevalence of SARS-CoV-2 antibodies in cancer patients and caregivers in a cancer hospital after the second COVID-19 outbreak in Thailand.
Study design: Cross-sectional study.
Methods: A SARS-CoV-2 seroprevalence cross-sectional survey was conducted among 200 cancer patients and 200 household caregivers in a tertiary cancer care hospital in Bangkok, Thailand. The survey took place between 4 March and May 31, 2021 - a time period covering the end of the second COVID-19 wave and the early phase of the third wave in Thailand.
Results: Rigorous personal and social measures to reduce viral spread among cancer patients and caregivers lead to an extremely low prevalence of SARS-CoV2 infection (0% among cancer patients and 1% among household caregivers).
Conclusion: This study demonstrates the importance of social distancing and personal hygiene measures for the prevention of SARS-CoV-2 infection, even when vaccine coverage is low.

Keywords: COVID-19; Cancer; Household caregiver; SARS-CoV-2; Seroprevalence; Thailand.
 
Back
Top Bottom